Search

everythinglearnresearchcommunity

for

Search:↓

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Lower vitamin D levels may contribute to female hair loss.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Environmental, chemical, mechanical, and personal health factors can all damage hair and contribute to hair loss or changes in hair quality.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Men with androgenetic alopecia may have higher cholesterol and triglycerides.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Birth control pills can help reduce mild to moderate acne in women.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.